Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Neovasc Inc.
NVCN
Healthcare
Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter...
treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NVCN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(3)
•••
pleazu69
X
View Profile
View Bullboard History
Post by
pleazu69
on Jun 21, 2018 8:03am
PR
That PR is worth more than 1/2 cent Patient doesn't "feel better" and cancel surgery. Finally some good PR ... Fred gets out of bed :) Lets hear partnership or BO next
...more
(0)
•••
Makstocks
X
View Profile
View Bullboard History
Comment by
Makstocks
on Jun 21, 2018 7:57am
RE:nvcn - stock prices it was 12 dollars
Copyright issues. 100+ million lawsuite
Xcyte Digital Corp. Releases "Xperience" Subscription Service
posted May 17, 2024 9:00am by
Xcyte Digital Corp.
-
|
"Xcyte anticipates growing the Xperience one-stop offering further with additional event technologies and supporting services, such as digital marketing and lead generation. We look forward to providing future updates as we execute upon this growth strategy ...read more
(8)
•••
Barewood
X
View Profile
View Bullboard History
Comment by
Barewood
on Jun 20, 2018 9:16pm
RE:nvcn - stock prices it was 12 dollars
Have you already put money on this without ding bit of research? Read the company news starting back mid year 2017 to start.
(101)
•••
Rustyred24
X
View Profile
View Bullboard History
Post by
Rustyred24
on Jun 20, 2018 7:52pm
nvcn - stock prices it was 12 dollars
how did it get here
(0)
•••
Up700Up
X
View Profile
View Bullboard History
Comment by
Up700Up
on Jun 20, 2018 3:44pm
RE:All trades by same buyer seller broker - why?
Finally a small amount of my ask is filled but a tiny amount and since then numerous others are filled. What the heck?
(3)
•••
pleazu69
X
View Profile
View Bullboard History
Post by
pleazu69
on Jun 20, 2018 3:18pm
up up up and away
frankfurt +36% nasdaq +20.6% tsx +11.11%
(0)
•••
Up700Up
X
View Profile
View Bullboard History
Post by
Up700Up
on Jun 20, 2018 12:28pm
All trades by same buyer seller broker - why?
This may be a dumb question but I noticed that all the trades are listing same buyer/seller broker. I don’t recall seeing so much of this with other stock sales. Can anyone enlighten me on this - I
...more
(8)
•••
Barewood
X
View Profile
View Bullboard History
Post by
Barewood
on Jun 20, 2018 11:49am
All we now is news
about approved amendments to the remaining 2017 financing and or NASDAQ approval for an extension!
(3)
•••
pleazu69
X
View Profile
View Bullboard History
Post by
pleazu69
on Jun 20, 2018 9:39am
premarket buying
on TSX. you dont see that too often... shorts covering?
(3)
•••
pleazu69
X
View Profile
View Bullboard History
Post by
pleazu69
on Jun 20, 2018 9:37am
L2
(3)
•••
pleazu69
X
View Profile
View Bullboard History
Comment by
pleazu69
on Jun 20, 2018 9:35am
RE:Darn It!!
lol - told you not to lose your patience... it happens all the time to me. NOW LET THE GAPS FILL
(0)
•••
Amor123
X
View Profile
View Bullboard History
Comment by
Amor123
on Jun 20, 2018 8:59am
RE:Compassionate use, the patient was not enrolled in the trial
That means US patients can have the Reducer even before the FDA approval, that's really a major devolleppment
(0)
•••
Amor123
X
View Profile
View Bullboard History
Post by
Amor123
on Jun 20, 2018 8:28am
Compassionate use, the patient was not enrolled in the trial
Expanded access (sometimes called “compassionate use”) is the use of investigational drugs, biologics or medical devices outside the clinical trial setting for treatment purposes. Expanded
...more
(0)
•••
onions7777
X
View Profile
View Bullboard History
Post by
onions7777
on Jun 20, 2018 8:22am
Darn It!!
Lost my patience with NVCN last night and sold for .0325 after hours. Of course PR comes out this morning and the price is spiking LOL. Goes to show you, listen to your gut and be patient. Oh well
...more
(0)
•••
tinymanipulator
X
View Profile
View Bullboard History
Post by
tinymanipulator
on Jun 19, 2018 10:26am
this is nvcn
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project